EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Temporal trends in gender‐affirming hormone therapy initiation: evidence from whole‐of‐population Australian administrative data

Karinna Saxby iD, Brendan J Nolan iD

Internal Medicine Journal · 2025-12 · 55 (12) · 2092-2094

DOI: 10.1111/imj.70194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, online erschienen am 10.09.2025. Verfasst von Karinna Saxby und 1 weiteren Autor:innen. Beteiligte Einrichtung: Applied Economic and Social Research, Faculty of Business and Economics, Melbourne Institute, University of Melbourne, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Transgender Persons, Testosterone, Hormone Replacement Therapy, Estrogens. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Melbourne McKenzie Fellowship, National Health and Medical Research Council, Viertel Charitable Foundation Clinical Investigator Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Using longitudinal national prescribing data, we estimated the number of transgender and gender‐diverse individuals initiating gender‐affirming hormone therapy (GAHT) from 2013 to 2024 in Australia. Between 2013 and 2024, 11 883 individuals initiated testosterone‐based GAHT and 20 358 initiated oestrogen‐based GAHT. Initiation rose from 1118 in 2013 to 5135 in 2024, with a growing share accessing testosterone‐based GAHT over time. The mean age at initiation also fell from 50 years in 2013 to 26 years in 2024. Our findings align with international trends, suggesting increasing demand among younger populations. This highlights the need for specialised, accessible gender‐affirming care in Australia and underscores the importance of improved data collection to inform health policy and clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transgender PersonsTestosteroneHormone Replacement TherapyEstrogensHumansAustraliaMaleFemaleAdultMiddle AgedYoung AdultAdolescentLongitudinal Studies

Stichwörter der Autor:innen

gender diversegender‐affirming hormone therapytransgender

Substanzen

TestosteroneEstrogens

Autor:innen und Institutionen

  • Applied Economic and Social Research, Faculty of Business and Economics, Melbourne Institute, University of Melbourne, Melbourne, Victoria, Australia.
  • Trans Health Research Group, Medicine (Austin Health), University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.
  • Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.

ORCID-Profile: Karinna Saxby, Brendan J Nolan

Förderung

  • University of Melbourne McKenzie Fellowship
  • National Health and Medical Research Council
  • Viertel Charitable Foundation Clinical Investigator Award

Zitieren

APA

Saxby, K., & Nolan, B. J. (2025). Temporal trends in gender‐affirming hormone therapy initiation: evidence from whole‐of‐population Australian administrative data. Internal Medicine Journal, 55(12), 2092-2094. https://doi.org/10.1111/imj.70194

Vancouver

Saxby K, Nolan BJ. Temporal trends in gender‐affirming hormone therapy initiation: evidence from whole‐of‐population Australian administrative data. Internal Medicine Journal. 2025;55(12):2092-2094. doi:10.1111/imj.70194

BibTeX
@article{Saxby2025,
  author = {Saxby, Karinna and Nolan, Brendan J},
  title = {Temporal trends in gender‐affirming hormone therapy initiation: evidence from whole‐of‐population Australian administrative data},
  journal = {Internal Medicine Journal},
  year = {2025},
  volume = {55},
  number = {12},
  pages = {2092--2094},
  doi = {10.1111/imj.70194}
}
Kostenlos starten →